Anti-MALT1 monoclonal antibody

Pre-made anti-MALT1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to MALT1/MALT1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T92678-Ab-1/ GM-Tg-hg-T92678-Ab-2Anti-Human MALT1 monoclonal antibodyHuman
GM-Tg-rg-T92678-Ab-1/ GM-Tg-rg-T92678-Ab-2Anti-Rat MALT1 monoclonal antibodyRat
GM-Tg-mg-T92678-Ab-1/ GM-Tg-mg-T92678-Ab-2Anti-Mouse MALT1 monoclonal antibodyMouse
GM-Tg-cynog-T92678-Ab-1/ GM-Tg-cynog-T92678-Ab-2Anti-Cynomolgus/ Rhesus macaque MALT1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T92678-Ab-1/ GM-Tg-felg-T92678-Ab-2Anti-Feline MALT1 monoclonal antibodyFeline
GM-Tg-cang-T92678-Ab-1/ GM-Tg-cang-T92678-Ab-2Anti-Canine MALT1 monoclonal antibodyCanine
GM-Tg-bovg-T92678-Ab-1/ GM-Tg-bovg-T92678-Ab-2Anti-Bovine MALT1 monoclonal antibodyBovine
GM-Tg-equg-T92678-Ab-1/ GM-Tg-equg-T92678-Ab-2Anti-Equine MALT1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T92678-Ab-1/ GM-Tg-hg-T92678-Ab-2; GM-Tg-rg-T92678-Ab-1/ GM-Tg-rg-T92678-Ab-2;
GM-Tg-mg-T92678-Ab-1/ GM-Tg-mg-T92678-Ab-2; GM-Tg-cynog-T92678-Ab-1/ GM-Tg-cynog-T92678-Ab-2;
GM-Tg-felg-T92678-Ab-1/ GM-Tg-felg-T92678-Ab-2; GM-Tg-cang-T92678-Ab-1/ GM-Tg-cang-T92678-Ab-2;
GM-Tg-bovg-T92678-Ab-1/ GM-Tg-bovg-T92678-Ab-2; GM-Tg-equg-T92678-Ab-1/ GM-Tg-equg-T92678-Ab-2
Products NameAnti-MALT1 monoclonal antibody
Formatmab
Target NameMALT1
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-MALT1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T92678-Ag-1Recombinant multi-species MALT1/ IMD12/ MLT protein


    Target information

    Target IDGM-T92678
    Target NameMALT1
    Gene ID10892,240354,307366,696354,476188,101088885,504994,100054579
    Gene Symbol and SynonymsA630046N12,D430033E09Rik,IMD12,MALT1,MLT,MLT1,PCASP1
    Uniprot AccessionQ9UDY8
    Uniprot Entry NameMALT1_HUMAN
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseCancer
    Gene EnsemblENSG00000172175
    Target ClassificationTumor-associated antigen (TAA)

    The target: MALT1, gene name: MALT1, also named as IMD12, MLT, MLT1, PCASP1. This gene encodes a caspase-like protease that plays a role in BCL10-induced activation of NF-kappaB. The protein is a component of the CARMA1-BCL10-MALT1 (CBM) signalosome that triggers NF-kappaB signaling and lymphoctye activation following antigen-receptor stimulation. Mutations in this gene result in immunodeficiency 12 (IMD12). This gene has been found to be recurrently rearranged in chromosomal translocations with other genes in mucosa-associated lymphoid tissue lymphomas, including a t(11;18)(q21;q21) translocation with the baculoviral IAP repeat-containing protein 3 (also known as apoptosis inhibitor 2) locus [BIRC3(API2)-MALT1], and a t(14;18)(q32;q21) translocation with the immunoglobulin heavy chain locus (IGH-MALT1). Alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, May 2018].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.